Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Model-based oral flucloxacillin therapy in children
NL-OMON58121Recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of flucloxacillin in bacterial disease, Not applicable and osteomyelitis (OM), sponsored by HagaZiekenhuis. Primary endpoints: Blood concentration of flucloxacillin, Population pharmacokinetic model for oral flucloxacillin in children and 1 more. Started Mar 2026; status: recruiting.
02
Drugs
flucloxacillin
03
Conditions
bacterial diseaseNot applicableosteomyelitis (OM)
Beyond the preview
Go deeper on NL-OMON58121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58121.